The James Bond franchise is currently in a state of flux. Even after the $880 million haul of Spectre, Ian Fleming’s iconic super-spy has quietly fallen onto the back-burner as Eon and MGM mull over the future of the franchise. Five studios are currently in the mix to land a one-picture deal for that lucrative license to kill – namely Warner Bros., Universal, 20th Century Fox, and Annapurna. Sony is also in contention, after the studio’s hold on the film rights expired with the release of Spectre.
Ditto for Daniel Craig, whose future in the title role of 007 is tentative at best. There is, however, reason to be hopeful, as the actor is seemingly on the verge of pulling a full U-turn to headline the as-yet-untitled Bond 25. Next on the to-do list then is locating a director to steer the tortured project into production.
Truth be told, there are still hurdles to overcome – Eon and MGM need to whittle down that aforementioned list of contenders and nominate a script for Bond 25. Until that domino falls, it’s unlikely we’ll hear anything official from the Powers That Be, but that has in no way slowed the rumor mill. For instance, an IMDb listing spotted today revealed that Christopher Nolan’s production company Syncopy was listed alongside Bond 25 on IMDb, fuelling rumors that the Dunkirk director was finally about to answer the question: “Just what would a Christopher Nolan-helmed James Bond movie look like?”
Don’t get too excited just yet, though; an update relayed by Twitter reveals that IMDb has since pulled Syncopy from the page.
UPDATE: @IMDb and IMDbPro are now removing #Bond25 from SYNCOPY's projects after *re-correcting* themselves. They messed up… Twice. pic.twitter.com/zhKav37rKz
— James Bond Film News (@BondFilmNews) May 4, 2017
So, there you have it; Bond 25 is still very much up in the air, and without a studio to call its own just yet, expect that radio silence to remain intact for the foreseeable future. Even still, the mere thought of Christopher Nolan taking point at the helm is enough to leave fans weak at the knees. But what do you think? As always, drop your thoughts, comments, and concerns down below.
